CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1 Study of Autologous Anti-CD45 CAR T Cells in Combination With CD45 Base Edited HSPCs in Patients With Relapsed or Refractory Hematologic Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07451054
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:18.368879+00:00
- Published At
- 2026-03-05T00:00:00+00:00
- Record Updated At
- 2026-03-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["B-Cell Non-Hodgkin Lymphoma (NHL)", "Richter\u0027s Transformation", "T-Cell Non-Hodgkin Lymphoma", "Hodgkin Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-05"- protocolSection.identificationModule.nctId
"NCT07451054"- protocolSection.identificationModule.officialTitle
"Phase 1 Study of Autologous Anti-CD45 CAR T Cells in Combination With CD45 Base Edited HSPCs in Patients With Relapsed or Refractory Hematologic Malignancies"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.